On the recordJune 16, 2009
Mr. Arny, with what considerations are you evaluating these applications?
Source
congress.govEditor's note · Context
Senator Burr asks about the evaluation criteria for applications.
Share & report
More from Richard Burr
Jan 10, 2022
I wrote the law. If--in the case of CDC, they were the delay to begin with, but to acquire testing, that falls in your lane.
Jan 10, 2022
This Administration has time and again squandered its opportunities and made worse in the decisions you have made on testing and treatment.
Apr 4, 2022
Why did FDA agree, and why did the industry agree to longer review times of 128 days on 510(k)'s and provide the agency with so much more money?
Jan 10, 2022
Well, get to the others. I mean this there is all--a sense of urgency here. I just think that might have been thought of before we did this.
Other voices in this conversation
